Min.Order / FOB Price:Get Latest Price
0 |
Negotiable |
Tandutinib Bulk Price Tandutinib Manufacturer Manufacturer Supply Tandutinib
Tandutinib is a novel oral small-molecule multi-target receptor tyrosine kinase inhibitor developed by Millennium Pharmaceuticals. , multiple myeloma, and myelodysplastic syndromes. It has inhibitory effects on receptor tyrosine kinases, including FMS-like tyrosine kinase-3 (FLT-3), PDGFR and stem cell factor receptor (c-KitR). Tandutinib inhibits the phosphorylation of FLT-3. In a phase I clinical trial, 40 patients with AML and myelodysplastic syndrome (MDS) were given oral tandutinib, and the results showed that the maximum tolerated dose (MTD) was 525 mg (bid), and showed some activity. Tandutinib is currently in Phase II clinical studies.
List of related drugs: Gefitinib
Imatinib mesylate
Lapatinib
sunitinib maleate
nilotinib
pazopanib
bosutinib
cicatinib
axitinib
masitinib
sunitinib malate
English name: Tandutinib
CAS number: 387867-13-2
Molecular formula: C31H42N6O4
Molecular weight: 562.7
Melting point: 177-178°C
Boiling point: 769.5±60.0°C (Predicted)
Density: 1.213±0.06g/cm3(Predicted)
Storage conditions: Sealedindry, Storeinfreezer, under-20°C
Solubility: Chloroform(Slightly), Methanol(Slightly)
Acidity coefficient: (pKa) 13.39±0.70 (Predicted)
Form:Solid
Color: White to Off-White
CAS NO:65-19-0
CAS NO:188627-80-7
CAS NO:103980-44-5
CAS NO:137-88-2
CAS NO:159351-69-6
CAS NO:163222-33-1
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View